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not be enoughTo the Editor,
Vascular access in hemodialysis patients is crucial. Vascular
access monitoring to ensure access patency is important
for patient survival, quality of life, and blood vessel care.
The ultrasound dilution method for measuring access ﬂow is
a screening tool to assess access dysfunction. Park et al. [1]
performed a single-center prospective study of the variation in
access ﬂow during hemodialysis, and we have some questions
and comments.
The study showed the effects of intradialytic change in
blood pressure and ultraﬁltration volume on the variation in
access ﬂow. As the authors mentioned, access ﬂow measure-
ment is useful for vascular access surveillance. However, what
canwe predict based on the variable ﬂows?We doubt whether
the ﬂow variation could help to predict vascular access events.
If patient data for vascular access events (thrombosis or stenosis)
were available, the authors would have more informative results.
According to the study reported by Park et al [1], the mean
vintage of access was almost 5 years with a wide range of
distribution. Because the duration of dialysis may inﬂuence the
vascular patency and blood ﬂow, previous studies enrolled
only the incident hemodialysis patients [2,3]. The sample size
in the study by Park et al [1] was too small to adjust for the
duration of dialysis.
Finally, the heterogeneity of vascular access should have been
considered in the data interpretation. Because arteriovenous
grafts and native ﬁstulae have completely different physiologies,
different cutoff values for vascular patency have been recom-
mended according to the vascular access type [3].Shin Young Ahn, Sejoong Kim
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in our article entitled “Effect of intradialytic change in blood
pressure and ultraﬁltration volume on the variation in access
ﬂow measured by ultrasound dilution” and for the interesting
commentary. Here I would like to provide responses to the
fundamental questions raised in their letter whether we can
predict vascular access stenosis or thrombosis by access ﬂow
surveillance.
In our center, we started monthly access ﬂow surveillance
by ultrasound dilution from December 2009, and referred the
patients for elective angiography when the access ﬂow has
decreased by 4 25% compared with a previous measurement
regardless of absolute values of access ﬂow or clinical signs. A
signiﬁcant stenosis was deﬁned as a decrease in vessel
diameters by 4 50% on angiographic images, together with
an increase in access ﬂow after percutaneous transluminal
angioplasty (PTA) of the stenotic lesions. Consequently, 68
patients were referred for angiography during the ﬁrst year (47
ﬁstulae, 21 grafts). Access ﬂow has decreased by 37.7% on
average (from 910 7 408 to 567 7 292 mL/min), and 84% of
the patients did not have any clinical sign of vascular access
stenosis. The angiography showed signiﬁcant stenosis in 94%
of the patients (outﬂow stenosis 54%, inﬂow stenosis 39%,
mixed stenosis 7%). Access ﬂow has increased to the previous
levels after PTA (from 567 7 292 to 960 7 374 mL/min). After
access ﬂow surveillance and preemptive PTA, the mean
thrombosis rate of arteriovenous ﬁstulae signiﬁcantly
decreased (0.51/1,000 access days in 2009 vs. 0.17/1,000 access
days in 2010 vs. 0.11/1,000 access days in 2011). These data are
planned for publication in a subsequent manuscript.
Drs. Ahn and Kim reported that low initial access ﬂow after
placement could be a risk factor for the vascular access patency. I
agree with them. However, low initial access ﬂow is only one of
the risk factors for the vascular access patency and does not
reﬂect vascular access stenosis. Vascular access surveillance for
stenosis is a totally different kettle of ﬁsh. It needs sequential
measurement of access ﬂow, and clinical decision for angiography
should be made by trend analysis, not by absolute values of
access ﬂow. The current international guidelines (NKF-KDOQIblished by Elsevier. This is an open access article under the CC BY-NC-
Ahn and Kim / Letter and Reply 143guidelines [1], European Best Practice Guidelines on Vascular
Access [2], Canadian Society of Nephrology guidelines [3])
recommend regular access ﬂow surveillance and preemptive
PTA, and I would suggest that we need to comply with them
until the new guidelines, which were based on the evidences
from randomized clinical trials, come out.Conﬂict of interest
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